网络药理学和分子动力学模拟揭示了南极海绵衍生的suberitenones的抗瘤潜力
Prasenjit Bhowmik1, Rahul Mallick2, Asim K Duttaroy3
1Department of Chemistry-BMC, Biochemistry, Disciplinary Domain of Science and Technology, Uppsala University, Uppsala, Sweden.
Frontiers in chemistry
|June 11, 2025
概括
海洋亚氨显示出作为抗癌剂的潜力. 计算分析确定了与关键癌症相关蛋白质具有高结合亲和度的特定化合物,建议进一步调查药物开发.
科学领域:
- 海洋天然产品化学 海洋天然产品化学
- 计算机化药物发现.
- 在瘤学瘤学.
背景情况:
- 与合成化合物相比,海洋天然产品在药物批准方面具有很高的成功率.
- 十一种亚基,氧化基,在体外细胞毒性较低时被确定.
- 这项研究研究了使用in silico方法的suberitenones的抗新形成潜力.
研究的目的:
- 通过计算分析评估suberitenones的抗瘤能力.
- 为了确定特定的suberitenones与与癌症相关的目标高结合亲和力.
- 为进一步对这些化合物的体外和体内研究提供基础.
主要方法:
- 定量结构-活动关系 (QSAR) 分析分析.
- 在ADMET预测预测.
- 对物质活动光谱的预测 (PASS)
- 网络药理学 网络药理学
- 分子对接是分子对接.
- 分子动力学模拟模型
主要成果:
- 分子对接显示了Suberitenone I (-8.9 kcal/mol) 与CASP3,Secosuberitenone A (-9.4 kcal/mol) 与MAPK3的高结合亲和力,以及Suberitenone J (-8.8 kcal/mol) 与EGFR的高结合亲和力.
- 分子动力学模拟支持了这些结合相互作用.
- 这些发现表明,研究中的suberitenones具有有希望的抗瘤性质.
结论:
- 苏贝利坦I,苏贝利坦A和苏贝利坦J显示出作为抗瘤剂的显著潜力.
- 这些已识别的化合物需要进一步进行体外和体内研究,以开发药物.
- 在 silico 分析提供了一个强大的平台来识别有前途的海洋天然产品用于癌症治疗.
关键词:
在CASP3中,CASP3是CASP3.欧洲农业基金会 (EGFR) 是一个基金.在MAPK3中使用MAPK3分子对接的分子对接.分子动力学模拟模拟网络药理学 网络药理学没有一个suberitenone.更多相关视频
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
2.6K
16:03A Fish-feeding Laboratory Bioassay to Assess the Antipredatory Activity of Secondary Metabolites from the Tissues of Marine Organisms
Published on: January 11, 2015
9.4K
相关概念视频
Structure-Activity Relationships and Drug Design
676
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
676
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
2.6K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.6K
